Takeda Pharmaceutical (TKPHF) FCF Payout Ratio Growth (1y) (2019 - 2026)
Takeda Pharmaceutical (TKPHF) FCF Payout Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 75.95% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Takeda Pharmaceutical | - | - | 4.39 Bn | -102.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.24% |
| Dec 31, 2025 | -5.91% |
| Sep 30, 2025 | 24.55% |
| Jun 30, 2025 | 9.02% |
| Mar 31, 2025 | -101.11% |
| Dec 31, 2024 | 52.52% |
| Sep 30, 2024 | 27.29% |
| Jun 30, 2024 | 35.83% |
| Mar 31, 2024 | 38.85% |
| Dec 31, 2023 | -128.00% |
| Sep 30, 2023 | 13.93% |
| Jun 30, 2023 | 7.34% |
| Mar 31, 2023 | -30.85% |
| Dec 31, 2022 | 10.72% |
| Sep 30, 2022 | -23.05% |
| Jun 30, 2022 | -51.93% |
| Mar 31, 2022 | 29.98% |
| Dec 31, 2021 | 35.97% |
| Sep 30, 2021 | -14.45% |
| Jun 30, 2021 | 14.78% |